EPIGENETICS MARKET SIZE & SHARE ANALYSIS - GROWTH TRENDS & FORECASTS (2023 - 2028)
Epigenetics Market Analysis:
The epigenetics market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 16.1% during the forecast period spanning from 2022 to 2027. The growth of this market has been significantly impacted by the COVID-19 pandemic, owing to the crucial role played by epigenetics in COVID-19 research. A study titled ‘The epigenetic implication in coronavirus infection and therapy’, published in Clinical Epigenetics in October 2020, highlights the potential role of epigenetic alterations in the onset of coronavirus disease complications. While several treatment options are being explored, further research is urgently required to identify a viable vaccine or safer chemotherapeutic medications, including epigenetic therapies, to combat this viral pandemic and establish pre- and post-exposure COVID-19 prophylaxis. This is expected to drive the adoption of epigenetics in the discovery of therapies for COVID-19 infection, thereby fueling the market growth over the forecast period.
The market growth is also expected to be driven by various factors, including the increasing prevalence of cancers, rising funding for research and development in healthcare, and growing applications of non-oncological applications of epigenetics. According to Globocan 2020, there were 19,292,789 new cancer cases reported worldwide, highlighting the urgent need for developing new cancer therapies that aid in risk assessment, early diagnosis, and effective treatment monitoring.
Get the free sample report of the Epigenetics Market
Comments
Post a Comment